FAP symposium another success at 2023 SNMMI meeting

June 25, 2023 – For the second year in a row, the spotlight shone on […]

2023-12-20T12:42:14+00:00July 7th, 2023|News|

RLS and SOFIE Enter Strategic Partnership for Distribution of Nuclear Medicine Doses for Patients

LAKE ZURICH, Il. and DULLES, Va. — June 21, 2023, RLS (USA), […]

2023-06-21T19:09:58+00:00June 21st, 2023|News|

Focus on FAPI Newsletter – Spring 2023

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

Dear FAPI community,

This quarter, the FAPI team celebrated […]

2023-06-12T22:46:31+00:00June 12th, 2023|Newsletter|

SOFIE partners with BAMF Health, diversifying sites for Phase II [68Ga]FAPI-46 study

SOFIE has added BAMF Health, a novel cancer treatment center in Grand Rapids, Michigan, as […]

2023-06-06T23:49:02+00:00June 6th, 2023|News|

First Patient Imaged in SOFIE’s 18F-FAPI Phase 2 trial

Dulles, VA –May 12, 2023 – SOFIE Biosciences (SOFIE), an established US manufacturer and developer […]

2023-05-13T14:53:26+00:00May 12th, 2023|News|

Focus on FAPI Newsletter – Winter 2023

A WORD FROM OUR CHIEF SCIENTIFIC OFFICER

Dear FAPI community,

We would like to wish you […]

2023-02-08T02:13:11+00:00February 5th, 2023|Newsletter|

FAPI PET: Fibroblast Activation Protein Inhibitor Use in Oncologic and Nononcologic Disease

Yuriko Mori 1Katharina Dendl 1Jens […]

2023-02-05T19:37:28+00:00February 5th, 2023|Publications|

Novel 68Ga-FAPI PET/CT offers oncologic staging without COVID-19 vaccine-related pitfalls

Tristan T Demmert 1Ines Maric 1

2023-02-05T19:37:35+00:00February 5th, 2023|Publications|

SOFIE and Mayo Clinic collaborate to secure $3M NIH grant for FAPI clinical trial

The National Cancer Institute (NCI) has awarded Mayo Clinic (Rochester), in partnership with SOFIE, a […]

2023-02-01T12:50:06+00:00January 31st, 2023|News|

IND granted for FAP targeting therapeutic in SOFIE partnership

Dulles, VA – January 17, 2023 – SOFIE Biosciences (SOFIE), an established US manufacturer and developer […]

2023-01-31T20:45:42+00:00January 17th, 2023|News|
Go to Top